Procrit news from FiercePharma
News
J&J's anemia med linked to stroke deaths
The FDA is sifting safety data on Johnson & Johnson's epoetin drug, which has come under a red flag thanks to a German stroke study. The study was testing high doses of Eprex (sold in the U.S. as... Read more...
Procrit linked to deaths in stroke trial
Another potential safety problem for anemia drugs: Johnson & Johnson announced that Procrit was linked to the deaths of some patients in a stroke study. Participants in the European trial were... Read more...
Anemia meds get tougher warnings
The labeling on Amgen and Johnson & Johnson's anemia meds is about to get even more... Read more...
EMEA advises against anemia meds
European regulators are taking a stand against anemia drugs. The European Medicines Agency says cancer patients with a "reasonably long life-expectancy" should get blood transfusions instead of... Read more...
Drugmakers to delay new-drug ads
There's a waiting period for marriage licenses, IPOs, and flood insurance -- and now, drug advertising. Several big drugmakers called on the Congressional carpet for their advertising campaigns now... Read more...
New drug-spending leader: Diabetes
New data on pharma sales details some big shifts in spending. Diabetes meds have displaced cholesterol drugs as the Read more...
Did FDA counsel save Procrit ads?
Remember that DTC hearing in Congress last week, when Rep.... Read more...
AMA calls for tighter DTC regulation
We all expected Democrats to rake DTC ads over the coals during yesterday's hearing before the House Energy and Commerce Committee's oversight arm. We expected Chairman Bart Stupak to call for... Read more...
Will DTC hearing lead to new regulation?
Will today's Congressional hearing on drug ads lead to new legislation? That's what Michigan... Read more...
J&J laying off 400 in marketing overhaul
With Procrit under siege, Johnson & Johnson wants to divert its promotional efforts elsewhere--a strategy that will lead to some 400 job cuts in its sales-and-marketing ranks. The company told... Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
